Remote Patient Monitoring for Heart Failure
(FAST-RPM-HF Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method for helping people with heart failure manage their condition from home using the VitalCare platform. Researchers aim to determine if remote patient monitoring (also known as remote physiologic monitoring or telehealth monitoring) can reduce hospital visits and improve patient engagement. Participants will use devices like a tablet and blood pressure cuff to track their health. Suitable candidates have heart failure with moderate symptoms, have been recently hospitalized for it, and are comfortable using a smartphone or tablet. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance heart failure management for many.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this remote patient monitoring method is safe for heart failure management?
Research shows that remote patient monitoring is generally safe for people with heart failure. Studies have found that remote monitoring tools, such as weight scales and blood pressure cuffs, do not cause serious side effects. These tools allow patients to track their health from home and have been used in other medical settings without major problems.
Remote monitoring can even help reduce hospital visits and lower the risk of heart-related issues by allowing early detection of symptoms. The equipment, like the VitalCare platform, is designed to be easy to use and reliable. Although this trial is new, similar tools have been well-received by patients in other studies.12345Why are researchers excited about this trial?
Researchers are excited about remote patient monitoring for heart failure because it offers a new way to manage the condition right from a patient's home. Unlike standard treatments, which often require frequent in-person visits to adjust medications or monitor symptoms, this method uses a tablet and connected devices like a weight scale and blood pressure cuff to track vital signs remotely. This approach allows for real-time data sharing with healthcare providers, potentially catching issues early and reducing hospital visits. By providing more personalized and immediate care, remote monitoring could significantly improve the quality of life for heart failure patients.
What evidence suggests that remote patient monitoring is effective for heart failure?
Research has shown that remote patient monitoring (RPM), which participants in this trial will receive, can benefit people with heart failure. Studies have found that RPM enables healthcare teams to monitor patients' health while they remain at home. This approach can reduce hospital readmissions and may even lower mortality rates for heart failure patients. By using devices like blood pressure cuffs and weight scales at home, patients can better manage their condition and detect problems early. Although early telemonitoring alone did not reduce hospital visits, it paved the way for more effective monitoring. These findings suggest RPM could be a promising tool for managing heart failure.12367
Are You a Good Fit for This Trial?
This trial is for adults with heart failure who've been hospitalized for it within the last year, can use a smartphone or tablet, and speak English. It's not for pregnant individuals, those awaiting a heart transplant, with severe kidney disease or very poor heart function (LVEF < 35%), or have certain implanted cardiac devices.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive remote patient monitoring using the VitalCare platform for heart failure management
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Remote Patient Monitoring
Remote Patient Monitoring is already approved in United States, European Union, Canada for the following indications:
- Chronic conditions such as hypertension, diabetes, asthma, COPD, congestive heart failure, and chronic kidney disease
- Cardiovascular diseases, diabetes, asthma, COPD, and chronic kidney disease
- Chronic conditions such as hypertension, diabetes, asthma, COPD, and chronic kidney disease
Find a Clinic Near You
Who Is Running the Clinical Trial?
Saint Luke's Health System
Lead Sponsor